BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20591029)

  • 1. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.
    Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S162-94. PubMed ID: 20591029
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes.
    Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S195-203. PubMed ID: 20591031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney disease in diabetology: lessons from 2008.
    Schernthaner G
    Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    J Hypertens; 2010 Feb; 28(2):408-10. PubMed ID: 20087106
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection.
    Kanda T; Wakino S; Hayashi K; Plutzky J
    J Am Soc Nephrol; 2008 Jan; 19(1):4-7. PubMed ID: 18178795
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    Acta Diabetol; 2010 Mar; 47(1):1-4. PubMed ID: 20099002
    [No Abstract]   [Full Text] [Related]  

  • 8. Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
    McCullough PA; Bakris GL; Owen WF; Klassen PS; Califf RM
    Am Heart J; 2004 Aug; 148(2):243-51. PubMed ID: 15308993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin II antagonist also protects the kidneys. 2 dialysis-free years for diabetics].
    MMW Fortschr Med; 2001 Oct; 143(43):50. PubMed ID: 11715881
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of end-stage renal disease due to type 2 diabetes.
    Hostetter TH
    N Engl J Med; 2001 Sep; 345(12):910-2. PubMed ID: 11565525
    [No Abstract]   [Full Text] [Related]  

  • 11. [IV. Management of diabetic neuropathy].
    Marre M
    J Mal Vasc; 2002 Dec; 27(5):274-5. PubMed ID: 12525775
    [No Abstract]   [Full Text] [Related]  

  • 12. [The NEPHRODIAB2 randomized trial].
    Villar E; Lièvre M; Labeeuw M; Pouteil-Noble C
    Nephrologie; 2003; 24(6):317-9. PubMed ID: 14584299
    [No Abstract]   [Full Text] [Related]  

  • 13. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus.
    Postma MJ; de Zeeuw D
    Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601
    [No Abstract]   [Full Text] [Related]  

  • 14. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current guidelines for the prevention and treatment of diabetic nephropathy. International Diabetes Federation].
    Bilo HJ
    Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1847-9. PubMed ID: 7477510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment possibilities for the diabetic with advanced renal insufficiency].
    Descoeudres C
    Ther Umsch; 1983 Oct; 40(10):899-907. PubMed ID: 6648847
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension in diabetes mellitus.
    Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
    Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitors as a shield against diabetic nephropathy.
    Materson BJ
    Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephropathy in patients with type 2 diabetes mellitus.
    Ritz E; Orth SR
    N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.